Ra Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
06 Mar 2019	Form 3: Ricardo Alonso, See Remarks Holds 14,285 shares of Common Stock
15 Nov 2018	Form 3: Cumbo Alexander, Director No securities owned
25 Sep 2018	Form 3: Brennan Aoife, Director No securities owned
23 Apr 2018	Form 3: King John C, Chief Commercial Officer No securities owned
25 Oct 2016	Form 3: Lubner David Charles, VP Operations & CFO
25 Oct 2016	Form 3: Treco Douglas A, Director Holds 204,292 shares of Common Stock
25 Oct 2016	Form 3: Morgenthaler Venture Partners Ix Lp, 10% owner and 1 other Holds 17,142 shares of Common Stock
25 Oct 2016	Form 3: Pearson Timothy R, Director
25 Oct 2016	Form 3: Bisgaard Peter, Director No securities owned
25 Oct 2016	Form 3: Shah Rajeev M., Director
25 Oct 2016	Form 3: Heft Robert, Director
25 Oct 2016	Form 3: Farzaneh-Far Ramin, Chief Medical Officer
25 Oct 2016	Form 3: Read Simon, Chief Scientific Officer
25 Oct 2016	Form 3: Weller Harry R, 10% owner
25 Oct 2016	Form 3: Viswanathan Ravi, 10% owner
25 Oct 2016	Form 3: Sandell Scott D, 10% owner
25 Oct 2016	Form 3: Mott David M, 10% owner
25 Oct 2016	Form 3: Mathers Edward T, Director No securities owned
25 Oct 2016	Form 3: Kolluri Krishna Kittu, 10% owner
25 Oct 2016	Form 3: Kerins Patrick J, 10% owner

Comments